M. Bruyn

发表

Therapeutic potential of Galectin‐9 in human disease

W. Helfrich, E. Bremer, V. R. Wiersma, 2013, Medicinal research reviews.

POLE proofreading domain mutation defines a subset of immunogenic colorectal cancers with excellent prognosis

D. Kerr, M. Delorenzi, R. Lothe, 2016 .

CD47, a multi-facetted target for cancer immunotherapy

W. Helfrich, E. Bremer, V. R. Wiersma, 2017 .

Targeting of Acute Myeloid Leukemia (AML) Stem Cells by scFv:Death Ligand fusion proteins with designed specificity for C-type Lectin-Like Molecule-1 (CLL-1)

G. Huls, W. Helfrich, E. Bremer, 2010 .

A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability

T. Bijma, G. Fey, G. Huls, 2009, Leukemia.

articleCarbon monoxide-Releasing Molecule-2 ( CORM-2 ) attenuates acute hepatic ischemia reperfusion injury in rats

Weihui Zhang, W. Helfrich, E. Bremer, 2015 .

Targeted delivery of CD 40 L promotes restricted activation of antigen-presenting cells and induction of cancer cell

H. Wajant, A. Rybczynska, H. Nijman, 2018 .

University of Groningen Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death

H. Wajant, A. Rybczynska, H. Nijman, 2014 .

Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program

J. Ledermann, T. Bosse, N. Singh, 2022, International Journal of Gynecological Cancer.

Both exposure to a novel context and associative learning induce an upregulation of AKAP150 protein in mouse hippocampus

E. Zee, P. Luiten, U. Eisel, 2007, Neurobiology of Learning and Memory.

University of Groningen Both exposure to a novel context and associative learning induce an upregulation of AKAP150 protein in mouse hippocampus Nijholt,

E. Zee, P. Luiten, U. Eisel, 2007 .

Aorto-pulmonary fistulation in the friesian horse : clinical characterization of 31 cases combined with histopathological features : lifting a tip of the veil

W. Back, A. Gröne, R. Ducatelle, 2011 .

University of Groningen CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy Komdeur,

H. Hollema, H. Klip, G. Wisman, 2017 .

ADOPTIVE T CELL THERAPY IN SOLID TUMORS

M. Bruyn, H. Lǒo, 2013 .

POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer Running title: POLE mutations and immune response in endometrial cancer Authors:

Marchi, Emanuele, P. Klenerman, 2015 .

University of Groningen Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer Stelloo,

H. Hollema, T. Bosse, V. Smit, 2016 .

Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy

C. Haie-meder, P. Pollock, H. Mackay, 2019, Annals of Oncology.

L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial–mesenchymal transition

X. Matías-Guiu, T. Bosse, C. Krakstad, 2018, Virchows Archiv.

University of Groningen L 1 CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition

X. Matías-Guiu, T. Bosse, C. Krakstad, 2018 .

MAPK pathway activity plays a key role in programmed death ligand-1 expression of EGFR wild-type non-small cell lung adenocarcinoma cells

R. Fehrmann, S. Jong, E. D. Vries, 2018 .

Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology.

W. Helfrich, E. Bremer, M. de Bruyn, 2010, Current drug targets.

The immune environment in ovarian cancer 1 2 3 4 5 6 7 8

H. Nijman, M. Bruyn, F. L. Komdeur, 2008 .

Antibody-Based Cancer Therapy: Successful Agents and Novel Approaches.

E. Bremer, M. de Bruyn, M. Bruyn, 2017, International review of cell and molecular biology.